Introduction {#s1}
============

Long-term exposure to fine particulate air pollution (PM~2.5~) has been associated repeatedly with cardiovascular and ischemic heart disease [@pmed.1001430-Brook1]. Several biological processes underlying these associations have been proposed, including oxidative stress and systemic inflammation, endothelial dysfunction, and alterations in autonomic tone. Toxicological data also indicate that PM~2.5~ can initiate or accelerate atherosclerosis [@pmed.1001430-Suwa1]--[@pmed.1001430-Chen1], yet there is little information to confirm this relation in humans.

Human investigations of prevalent atherosclerosis and air pollution have suggested a relation but are inconclusive. In cross-sectional analyses of older adults, 10 µg/m^3^ greater long-term concentrations of PM~2.5~ were associated with a 1%--10% larger intima-medial thickness of the common carotid artery (IMT) [@pmed.1001430-Roux1]--[@pmed.1001430-Bauer1]. In young adults, a positive but non-significant association has also been reported [@pmed.1001430-Lenters1]. Other atherosclerosis measures such as coronary artery calcium and ankle brachial index have been linked to traffic exposures [@pmed.1001430-Hoffmann1],[@pmed.1001430-Hoffmann2], a source of PM~2.5~, but have shown less consistent associations with PM~2.5~ itself [@pmed.1001430-Roux1]. Conversely, prevalent aortic calcium was linked to PM~2.5~ but not traffic [@pmed.1001430-Allen1]. Only one investigation to date has examined relations between air pollution and the progression of atherosclerosis in humans: both closer proximity to traffic sources and higher PM~2.5~ [@pmed.1001430-Kunzli2] were linked to greater progression of IMT in 1,483 older adults from Los Angeles. Replication of these findings in a more general population is needed, however, as participants of that study originated from five different clinical trials of vitamin, hormone, and anti-diabetes therapies and associations with IMT were limited to those in the treated groups. In addition, that investigation relied exclusively on regulatory monitoring data for assignment of air pollution concentrations and may have had insufficient information to fully capture fine-scale variability in pollution across different locations.

The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) was designed to investigate associations between long-term PM~2.5~ exposures and the progression of atherosclerosis over a 10-y follow-up period using information from the large population-based MESA cohort who were without pre-existing cardiovascular disease at baseline [@pmed.1001430-Kaufman1]. In this report, we present associations between individual-level PM~2.5~ estimated using measurements and models specific to this project and IMT progression over the first three MESA examinations. We hypothesized that persons living in areas with high PM~2.5~ during the follow-up period would experience a faster rate of progression than other individuals and that PM~2.5~ preceding the baseline exam would be related to baseline IMT.

Methods {#s2}
=======

Study Population {#s2a}
----------------

Participants of MESA with any IMT measurements in the first three clinical visits (2000--2005) who consented to having their home addresses geocoded were examined. While IMT measurements were also collected in later clinical visits of the MESA study, these data were collected from a different portion of the vessel and must be explored separately. At baseline, MESA was composed of 6,814 white, African-American or black, Spanish/Hispanic/Latino, and Chinese adults (aged 45--84 y) without clinical cardiovascular disease from six US communities (Baltimore, MD; Chicago, IL; Forsyth County, NC; Los Angeles County, CA; Northern Manhattan and Southern Bronx, NY; and St Paul, MN) [@pmed.1001430-Bild1]. Each field center developed recruitment procedures according to the characteristics of its community, past experience, available resources, and site-specific logistics. Recruitment sources included lists from county assessors, the Department of Motor Vehicles, local labor unions, commercial mailers, and random digit dialing. Friends, family, and persons serviced by the Centers for Medicare and Medicaid Services were also contacted to facilitate the target recruitment in upper age groups. This study met with the guidelines of the Declaration of Helsinki. Institutional review board approval was granted at each study site and written informed consent was obtained from all participants. We restricted our primary analyses to participants with complete covariate information.

Common Carotid IMT {#s2b}
------------------

Trained technicians captured images of the right common carotid artery from supine participants using high resolution B-mode ultrasound (Logiq 700, 13MHz; GE Medical Systems). Images collected over a distance 10 mm proximal to the common carotid bulb were transferred from each study center to the Tufts Medical Center for quantification [@pmed.1001430-Bild1]. This analysis examined the mean far wall thickness of the right common carotid, retrospectively gated to end-diastole. Blinded replicate readings gave inter-reader intra-class correlation coefficients of 0.84 and 0.86 for two separate sets of readers [@pmed.1001430-Miller1]. IMT was collected from all participants at baseline with follow-up measures collected on a subset in exam 2 and a different subset in exam 3.

Participant Characteristics {#s2c}
---------------------------

Information regarding participant demographics, medical history, and medications were obtained at each MESA exam through interviewer-administered questionnaires. Race/ethnicity was assessed by participant questionnaire where they were asked to report if they were best described as African-American or black, Asian (Chinese, Filipino, Japanese, Korean, Vietnamese, Asian Indian), white, Native Hawaiian or other Pacific Islander (Guamanian or Chamorro, Samoan, Micronesian, Tahitian), or American Indian or Alaska Native. Participants were also asked if they described themselves as Spanish/Hispanic/Latino and they were permitted to select more than one group. Participants reporting African-American or black, white, Spanish/Hispanic/Latino, or Chinese were eligible for participation. Measurements of anthropometry as well as serum levels of high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, glucose, homocysteine, and inflammatory markers were also collected [@pmed.1001430-Bild1]. Residential addresses were gathered and assigned geographic coordinates using ArcGIS v9.1 (ESRI) on the basis of the Dynamap 2000 street network (TeleAtlas).

Air Pollution Concentrations {#s2d}
----------------------------

Individual-level, long-term PM~2.5~ concentrations were estimated by MESA Air for the MESA cohort using area-specific hierarchical spatio-temporal models described elsewhere [@pmed.1001430-Sampson1],[@pmed.1001430-Szpiro1]. Predictions were derived from 2-wk average PM~2.5~ concentrations from the Environmental Protection Agency\'s Air Quality System (AQS) and supplemental monitoring specific to MESA Air [@pmed.1001430-Cohen1]. These models decompose the space-time field of concentrations into spatially varying long-term averages, spatially varying seasonal and long-term trends, and spatially correlated but temporally independent residuals. Each model utilized spatial covariates such as proximity to roadways and local land uses to predict outdoor concentrations at subjects\' homes between 1999 and 2007. City-specific cross-validated root mean square errors for these predictions ranged between 4.7% and 9.5% of long-term average concentrations at MESA Air monitoring locations.

Historical exposures accounting for residential history were estimated for each participant on the basis of concentrations for the year preceding their baseline exam. Exposure between ultrasounds was estimated by taking the time-weighted average of concentrations at a participant\'s residence or residences for the period between baseline and the follow-up exam. We also explored associations of IMT progression with the difference in exposures between the follow-up period and baseline levels as well as with average concentrations of PM~2.5~ measured at the nearest AQS monitor over the year before baseline and with living near a major roadway (i.e., within 100 m of an interstate or US highway or within 50 m of a state or county highway as defined by the US Census Feature Class Codes A1, A2, and A3).

Statistical Analysis {#s2e}
--------------------

A longitudinal mixed model [@pmed.1001430-Singer1] was fit with random slopes and intercepts for each subject in R v.2.10.1 [@pmed.1001430-RCoreTeam1]. As discussed in detail in [Text S1](#pmed.1001430.s001){ref-type="supplementary-material"}, this model simultaneously examined the association between IMT at baseline and PM~2.5~ levels preceding the baseline exam (henceforth referred to as "cross-sectional association") as well as IMT progression as a function of the average concentration over follow-up (henceforth referred to as "longitudinal association"). We also fit the same model examining cross-sectional and longitudinal associations and baseline PM~2.5~ as well as longitudinal associations with the change in PM~2.5~ between follow-up and baseline, defined as the average PM~2.5~ over follow-up minus baseline PM~2.5~. This specification allowed us to independently assess the associations of IMT progression with each of these two distinct exposures.

All models were constructed in a staged manner to assess the sensitivity of our results to control for different risk factors, including some that may possibly be mediators of the association between air pollution and IMT. In our minimally adjusted models, we explored confounding by age, sex, and race/ethnicity. Our moderately adjusted models added control for education, a neighborhood socio-economic score (derived from census tract level data on education, occupation, median home values, and median household income) [@pmed.1001430-Hajat1], adiposity (1/height, 1/height^2^, weight, waist, and 1/hip), and pack-years at baseline as well as a time-varying smoking status. Our main models further adjusted for time-varying HDL, total cholesterol, statin use, diabetes mellitus (using the 2003 ADA fasting criteria algorithm [@pmed.1001430-Genuth1]), systolic blood pressure, diastolic blood pressure, hypertensive diagnosis, and hypertensive medications. For sensitivity analyses, we tested an extended model that also included physical activity, alcohol use, second-hand smoke exposures, C-reactive protein, creatinine, fibrinogen, occupation, and neighborhood noise. Although we also considered changes in healthy food stores over the follow-up period from the National Establishment Time Series database (Walls & Associates) as an indicator of neighborhood change, it was uncorrelated with changes in pollution (ρ: −0.03 to −0.13) and thus not included in our models. All covariates were included as possible confounders of associations of PM~2.5~ with baseline IMT (cross-sectional associations) and with progression in IMT (longitudinal associations). Since metropolitan area was also considered to be an important potential confounder, models were constructed with and without fixed effects for clinic.

Although our models control for baseline IMT by including key predictors of IMT at baseline, we also explored a model of the change in IMT between the baseline and follow-up exams as the outcome normalized by the time between visits. Effect modification was also examined by age, gender, race/ethnicity, education, obesity, diabetes, hypertension, statin therapy, and baseline IMT. Standard model diagnostics were explored including graphics of residuals for evidence of non-normality, influential outliers, and omitted covariates.

Results were reported scaled to inter-quartile range of 2.5 and 1 µg/m^3^ for PM~2.5~ and the change in PM~2.5~ over the follow-up period, respectively. To illustrate our findings graphically, we present mean IMT levels and confidence intervals around those means for follow-up concentrations 3, 5, and 7 µg/m^3^ larger than the city average.

Results {#s3}
=======

Between exams 1 and 3, 11,270 valid IMT measurements were collected from 5,660 participants. By design, approximately half of the participants were sampled in exam 2 (*n* = 2,907) and half in exam 3 (*n* = 2,726), with 99% contributing two samples per person. Excluding 645 observations with missing covariate information, and 513 with missing exposures resulted in 10,220 observations for this analysis. The 5,362 included participants (52% female) had a mean age of 62 y and were 40% white, 27% black, 21% Hispanic, and 12% Chinese ([Table 1](#pmed-1001430-t001){ref-type="table"}). Overall, 44% had hypertension, 12% had diabetes, and nearly 50% were former or current smokers at baseline. Some differences were observed between the MESA clinics with respect to race, ethnicity, and socio-economic features. New York and Los Angeles had a higher fraction of their populations without high school educations whereas Baltimore, Chicago, and Winston-Salem had larger fractions of participants with graduate degrees.

10.1371/journal.pmed.1001430.t001

###### Study population characteristics presented as mean (standard deviation) or percent.

![](pmed.1001430.t001){#pmed-1001430-t001-1}

  Characteristics                         Overall     Winston Salem    New York    Baltimore     St Paul      Chicago     Los Angeles
  ------------------------------------- ------------ --------------- ------------ ------------ ------------ ------------ -------------
  **Number of samples**                                                                                                  
  Baseline                                 5,276           856           835          734          847          986          1,018
  Follow-up                                4,944           797           795          690          777          948           937
  **IMT**                                                                                                                
  Baseline (µm)                          678 (189)      725 (207)     677 (173)    695 (191)    641 (165)    647 (180)     690 (199)
  Progression (µm/y)                      14 (53)        13 (56)        9 (50)      19 (65)      15 (49)      19 (55)       12 (43)
  Follow-up time (y)                     2.5 (0.8)      2.4 (0.8)     2.6 (0.7)    2.4 (0.8)    2.4 (0.9)    2.3 (0.8)     2.5 (0.9)
  **Air pollution concentrations**                                                                                       
  Baseline PM~2.5~ (µg/m^3^)             16.6 (3.7)    15.5 (0.7)     15.5 (0.8)   15.2 (0.9)   11.9 (1.1)   16.9 (1.2)    23 (1.9)
  Average follow-up PM~2.5~ (µg/m^3^)    15.5 (3.5)    14.5 (0.7)     15.0 (0.7)   14.9 (0.8)   10.4 (0.7)   15.5 (1.1)   21.4 (1.8)
  Delta PM~2.5~ (µg/m^3^)                −1.1 (1.1)    −1.1 (0.4)     −0.5 (0.4)   −0.3 (0.5)   −1.4 (0.9)   −1.4 (0.8)   −1.6 (1.9)
  **Personal characteristics**                                                                                           
  Age (y)                                 62 (10)        62 (10)       62 (10)      63 (10)      60 (10)      62 (10)       63 (11)
  Female (%)                                 52            53             55           52           50           54           50
  Race/ethnicity (%)                                                                                                     
  White                                      40            53             20           51           60           49           12
  Black                                      27            47             33           49           0            25           12
  Chinese                                    12             0             0            0            0            26           38
  Hispanic                                   21             0             47           0            40           0            39
  Education (%)                                                                                                          
  Less than high school                      16             7             25           10           16           7            31
  High school                                18            22             18           19           22           8            19
  Higher education                           47            52             41           48           51           49           41
  Advanced degree                            19            19             16           22           11           36            9
  Smoking status (%)                                                                                                     
  Never                                      51            45             52           47           44           52           63
  Former                                     37            43             34           40           41           37           28
  Current                                    12            13             14           12           15           11            9
  **General health characteristics**                                                                                     
  Body mass index (kg/m^2^)              28.2 (5.3)    28.7 (5.2)     28.7 (5.3)   29.3 (5.6)   29.4 (5.1)    26.7 (5)     27 (5.2)
  Systolic BP (mm Hg)                     126 (21)      133 (21)       125 (21)     128 (21)     122 (20)     123 (21)     126 (22)
  Diastolic BP (mm Hg)                    72 (10)        74 (10)       73 (10)      72 (10)      70 (10)      71 (10)       71 (10)
  HDL (mg/dl)                             51 (15)        51 (15)       53 (15)      52 (15)      49 (14)      54 (16)       49 (14)
  LDL (mg/dl)                             117 (31)      114 (30)       118 (32)     118 (31)     121 (31)     117 (31)     117 (31)
  CRP (mg/dl)                            3.7 (5.6)      4.4 (6.6)     3.4 (4.2)    4.0 (5.7)    3.9 (5.5)    3.1 (5.7)     3.3 (5.4)
  Hypertension (%)                           44            54             47           50           34           37           42
  Statin users (%)                           15            16             16           19           12           15           13
  Diabetes (%)                               12            11             13           13           10           8            15

Personal characteristics as reported at baseline. 86 participants had follow-up IMT measurements without valid baseline IMT measurements. Hypertension was defined by diastolic blood pressure ≥90, a systolic blood pressure ≥140 or self-reported history of hypertension with use of hypertensive medications.

CRP, C-reactive protein.

Among the whole population, we observed a mean baseline IMT of 678 µm and progression of 14 µm/y over a mean follow-up of 2.5 y. The mean long-term PM~2.5~ concentration was 16.6 µg/m^3^±3.7 µg/m^3^ with a range of 9.4 to 27.5 µg/m^3^. Concentrations were substantially more variable across areas (standard deviation: 3.5 µg/m^3^) than within areas (average standard deviation: 1.11µg/m^3^). As shown in [Table 1](#pmed-1001430-t001){ref-type="table"}, all areas exhibited a decrease in PM~2.5~ concentrations over the follow-up period (mean change: −1.1±1.1 µg/m^3^) but regions with higher baseline PM~2.5~ concentrations experienced the largest reductions over the follow-up period (overall ρ for baseline and change in PM~2.5~: −0.32 and average within-area ρ: −0.54). Concentrations at regulatory monitors also demonstrated similar patterns. While Chicago and New York had large fractions of their cohort living near major roadways (30% and 57%, respectively), in the other areas approximately 20% of the cohort resided in close proximity to a major roadway. Virtually no participants (\<0.1%) changed residential proximity to roadways over follow-up.

Average PM~2.5~ concentrations over follow-up showed consistent positive associations with IMT progression in all models following adjustment for metropolitan area, with areas of higher concentrations showing steeper progressions of IMT over time ([Figure 1](#pmed-1001430-g001){ref-type="fig"}). Living at a residence with a 2.5 µg/m^3^ higher concentration (inter-quartile range \[IQR\]) during the follow-up period was associated with a 5.0 µm/y (95% CI 2.6 to 7.4 µm/y) faster change in IMT over time when compared to others in the same metropolitan area ([Table 2](#pmed-1001430-t002){ref-type="table"}). Models that simultaneously explored associations with baseline PM~2.5~ and the change in PM~2.5~ over the follow-up period similarly indicated that a 2.5 µg/m^3^ larger baseline PM~2.5~ was associated with a 3.8 µm/y (95% CI 1.2 to 6.4 µm/y) faster rate of progression among persons with the same change since baseline. In addition, a 1 µg/m^3^ greater reduction in PM~2.5~ over follow-up was associated with a 2.8 µm/y (95% CI 1.6 to 3.9 µm/y) slower rate of IMT progression ([Table 3](#pmed-1001430-t003){ref-type="table"}) after control for metropolitan area and concentration preceding the baseline exam.

![Estimated IMT (95% CIs) over time at varying levels of average residential PM~2.5~ concentrations exceeding the city average during the follow-up period.\
IMT estimated from results reported in [Table 1](#pmed-1001430-t001){ref-type="table"} assuming a group of white women of average age, body mass index, LDL cholesterol, systolic and diastolic blood pressure, C-reactive protein, glucose, and baseline exposures to air pollution who never smoked, were not on hypertensive medications, and were in the lowest income and education groups. Results are reported for concentration increments above the city mean with confidence intervals around the mean.](pmed.1001430.g001){#pmed-1001430-g001}

10.1371/journal.pmed.1001430.t002

###### Mean differences (95% CI) in IMT at baseline and in IMT progression over time associated with PM~2.5~ concentrations prior to baseline and averaged over follow-up, with and without control for metropolitan area.

![](pmed.1001430.t002){#pmed-1001430-t002-2}

  Model                                                                         Overall Associations   Within-City Associations
  ---------------------------------------------------------------------------- ---------------------- --------------------------
  **Baseline IMT (µm) per 2.5 µg/m^3^ of baseline PM~2.5~**                                           
  Minimal adjustment                                                              6.1 (2.6 to 9.6)        3.3 (−5.9 to 12.5)
  Moderate adjustment                                                            6.6 (3.1 to 10.2)        1.0 (−8.6 to 10.5)
  Main model                                                                      6.3 (2.8 to 9.8)        0.4 (−9.1 to 9.9)
  Extended adjustment                                                             5.7 (1.5 to 9.8)        1.1 (−9.8 to 12.0)
  **Progression of IMT (µm/y) per 2.5 µg/m^3^ of average follow-up PM~2.5~**                          
  Minimal adjustment                                                             0.4 (−0.4 to 1.2)         4.8 (2.4 to 7.1)
  Moderate adjustment                                                            0.5 (−0.3 to 1.3)         4.9 (2.5 to 7.3)
  Main model                                                                     0.4 (−0.4 to 1.2)         5.0 (2.6 to 7.4)
  Extended adjustment                                                            0.5 (−0.4 to 1.5)         4.4 (1.6 to 7.3)

Minimal adjustment included age, sex, and race/ethnicity. Moderately adjustment added control for education, a neighborhood socio-economic score (derived from census tract level data on education, occupation, median home values, and median household income), adiposity (1/height, 1/height^2^, weight, waist, and 1/hip), and pack-years at baseline as well as a time-varying smoking status. Main models further adjusted for HDL, total cholesterol, statin use, diabetes mellitus (using the 2003 ADA fasting criteria algorithm), systolic blood pressure, diastolic blood pressure, hypertensive diagnosis, and hypertensive medications. In sensitivity analyses, we tested an extended model that also included physical activity, second-hand smoke exposures, alcohol use, C-reactive protein, creatinine, fibrinogen, occupation, and neighborhood noise among a smaller subset of the population with complete data.

10.1371/journal.pmed.1001430.t003

###### Mean differences (95% CI) in IMT at baseline and in IMT progression over time associated with PM~2.5~ concentrations prior to baseline and change between follow-up and baseline, with and without control for metropolitan area.

![](pmed.1001430.t003){#pmed-1001430-t003-3}

  Model                                                                         Overall Associations   Within-City Associations
  ---------------------------------------------------------------------------- ---------------------- --------------------------
  **Mean IMT (µm) per 2.5 µg/m^3^ of baseline PM~2.5~**                                               
  Minimal adjustment                                                              6.4 (2.9 to 9.9)        5.4 (−4.0 to 14.7)
  Moderate adjustment                                                            7.0 (3.4 to 10.5)        3.3 (−6.5 to 13.0)
  Main model                                                                     6.7 (3.2 to 10.2)        2.7 (−6.9 to 12.4)
  Extended adjustment                                                            6.0 (1.8 to 10.1)        3.2 (−8.0 to 14.3)
  **IMT progression (µm) per 2.5 µg/m^3^ of baseline PM~2.5~**                                        
  Minimal adjustment                                                             0.3 (−0.5 to 1.1)         3.7 (1.3 to 6.2)
  Moderate adjustment                                                            0.3 (−0.5 to 1.1)         3.7 (1.1 to 6.3)
  Main model                                                                     0.3 (−0.6 to 1.1)         3.8 (1.2 to 6.4)
  Extended adjustment                                                            0.4 (−0.5 to 1.4)         3.5 (0.5 to 6.5)
  **IMT progression (µm) per 1 µg/m^3^ of change in PM~2.5~ over follow-up**                          
  Minimal adjustment                                                              1.1 (0.2 to 2.0)         2.7 (1.6 to 3.8)
  Moderate adjustment                                                             1.2 (0.3 to 2.1)         2.7 (1.6 to 3.9)
  Main model                                                                      1.3 (0.4 to 2.2)         2.8 (1.6 to 3.9)
  Extended adjustment                                                            1.0 (−0.1 to 2.0)         2.5 (1.1 to 3.9)

Change was defined as the average concentration over the follow-up period: concentration at baseline such that a reduction in concentrations over time would have a negative change and increases in concentrations over time would be manifest as a positive change. Minimal adjustment included age, sex, and race/ethnicity. Moderately adjustment added control for education, a neighborhood socio-economic score (derived from census tract level data on education, occupation, median home values, and median household income), adiposity (1/height, 1/height^2^, weight, waist, and 1/hip), and pack-years at baseline as well as a time-varying smoking status. Main models further adjusted for HDL, total cholesterol, statin use, diabetes mellitus (using the 2003 ADA fasting criteria algorithm), systolic blood pressure, diastolic blood pressure, hypertensive diagnosis, and hypertensive medications. In sensitivity analyses, we tested an extended model that also included physical activity, alcohol use, second-hand smoke exposures, C-reactive protein, creatinine, fibrinogen, occupation, and neighborhood noise among a smaller subset of the population with complete information.

Without control for metropolitan area, associations between IMT progression and the average PM~2.5~ concentration over follow-up (0.4 µm/y \[95% CI −0.4 to 1.2 µm/y per 2.5 µg/m^3^\]) were positive but could not be distinguished from no association. The same was true for associations between progression and baseline PM~2.5~ in models controlled for the change in pollution over follow-up (0.3 µm/y \[95% CI −0.6 to 1.1 µm/y\] per 2.5 µg/m^3^). In all of the six metropolitan areas, however, increased IMT progression was observed with larger PM~2.5~ concentrations ([Figure 2](#pmed-1001430-g002){ref-type="fig"}). Also, the change in PM~2.5~ over the follow-up period remained associated with IMT progression (1.3 µm/y reduction \[95% CI 0.4 to 2.2 µm/y\] per µg/m^3^ reduction in PM~2.5~), even without control for metropolitan area.

![Mean difference in IMT progression (µm/y, 95% CI) per 2.5 µg/m^3^ PM~2.5~ concentration averaged over follow-up in select stratified analyses controlled for metropolitan area.\
Models controlled for age, sex, race/ethnicity, education, a neighborhood socio-economic score (derived from census tract level data on education, occupation, median home values, and median household income), adiposity (1/height, 1/height^2^, weight, waist, and 1/hip), pack-years at baseline, smoking status, HDL, total cholesterol, statin use, diabetes mellitus (using the 2003 ADA fasting criteria algorithm), systolic blood pressure, diastolic blood pressure, hypertensive diagnosis, hypertensive medications, and metropolitan area.](pmed.1001430.g002){#pmed-1001430-g002}

Cross-sectional associations with baseline IMT could not be differentiated from no effect (0.4 µm \[95% CI −9.1 to 9.9 µm\] \[[Table 2](#pmed-1001430-t002){ref-type="table"}\] to 2.7 µm \[95% CI −6.9 to 12.4 µm\] \[[Table 3](#pmed-1001430-t003){ref-type="table"}\]) after adjustment for the mean concentration for each metropolitan area. Associations with baseline IMT were stronger without control for metropolitan area. In these models, a 2.5 µg/m^3^ higher baseline PM~2.5~ concentration was associated with a 6.3 µm (95% CI 2.8--9.8 µm \[[Table 2](#pmed-1001430-t002){ref-type="table"}\]) to 6.7 µm (95% CI 3.2--10.2 µm, \[[Table 3](#pmed-1001430-t003){ref-type="table"}\]) larger baseline IMT.

Sensitivity analyses demonstrated that our findings were robust to increasing degree of control for an expanded covariate list (extended adjustment, [Tables 2](#pmed-1001430-t002){ref-type="table"} and [3](#pmed-1001430-t003){ref-type="table"}), restriction to residentially stable participants (no moves within 10 y, [Figure 2](#pmed-1001430-g002){ref-type="fig"}), and alternate modeling strategies including a model of the change in IMT over the follow-up period as a function of the change in PM~2.5~ (see [Text S1](#pmed.1001430.s001){ref-type="supplementary-material"}). Furthermore, qualitatively similar associations for baseline IMT and IMT progression were found for concentrations estimated by the nearest regulatory monitor. Living near a major roadway was not associated with a smaller baseline IMT or progression of IMT ([Text S1](#pmed.1001430.s001){ref-type="supplementary-material"}).

Associations between PM~2.5~ and IMT and progression generally showed very little difference by risk factors examined, though stronger associations were suggested for some subgroups including women, diabetics, hypertensives, and residents of St Paul ([Figure 2](#pmed-1001430-g002){ref-type="fig"}).

Discussion {#s4}
==========

In a large prospective cohort study of adults without pre-existing cardiovascular disease, we found evidence that individuals with higher long-term residential concentrations of PM~2.5~ experience a faster rate of IMT progression as compared to other people within the same metropolitan area. Improvements in air quality over the duration of the study were similarly associated with changes in IMT progression, with greater reductions in PM~2.5~ showing slower IMT progression. These findings suggest that higher long-term PM~2.5~ exposures may be associated with an acceleration of vascular pathologies over time. As such, they may help explain why epidemiological studies have repeatedly found much larger associations between mortality and chronic air pollution exposures than can be explained by short-term triggering of cardiovascular events alone. Our findings furthermore bolster recent reports that falling pollution levels in the United States after the adoption of the Clean Air Act are associated with reduced mortality [@pmed.1001430-Laden1] and increased life expectancy [@pmed.1001430-Pope1],[@pmed.1001430-Correia1].

Our results indicate that persons living in residences with a 2.5 µg/m^3^ greater PM~2.5~ concentration could experience a 5.0 µm/y (95% CI 2.6--7.4 µm/y) faster rate of IMT progression than other persons in the same city. Similarly, a person who experienced a 1 µg/m^3^ larger reduction in PM~2.5~ over the follow-up period would have a 2.8 µm/y (95% CI 1.6--3.9 µm/y) slower IMT progression than another in the same city with the same baseline PM~2.5~. Although a recent meta-analysis [@pmed.1001430-Lim1] raises some questions as to the exact clinical implications of a larger IMT progression, results from the MESA cohort [@pmed.1001430-Miller1] suggest that participants living in parts of town with 2.5 µg/m^3^ higher concentrations of PM~2.5~ would have a 2% relative increase risk in stroke as compared to persons in a less polluted part of the metropolitan area. These findings have practical relevance since associations with IMT progression were found at concentrations commonly occurring in developed nations and well below those in developing countries. Although our mean long-term concentrations (range 10--23 µg/m^3^) were slightly above the new annual average US National Ambient Air Quality Standard of 12 µg/m^3^ and the World Health Organization guideline of 10 µg/m^3^, our findings are expected to hold even at lower concentrations as past evidence suggests that there is likely no safe threshold for air pollution [@pmed.1001430-USEPA1].

The acceleration of atherosclerosis has been proposed as a possible mechanism linking chronic exposures to air pollution to clinical cardiovascular disease [@pmed.1001430-Dockery1]--[@pmed.1001430-Miller2]; yet this is only the second publication to investigate the longitudinal relationships between air pollution and a surrogate of atherosclerosis in humans. Our findings support the hypothesis proposed by Künzli and colleagues [@pmed.1001430-Knzli1] that persons living in areas with higher long-term concentrations of PM~2.5~ may experience a more rapid development of vascular pathologies, which leads to the development of clinically relevant atherosclerosis at an earlier age, and increases the population at risk of cardiovascular events. Our findings that concentrations preceding baseline had slightly weaker associations with IMT progression per unit change than those during the follow-up period may indicate the importance of recent exposures or reduced exposure measurement error during the study period.

The magnitude of our findings are consistent with Künzli et al., which reported a 0.6 µm/y (95% CI −0.1 to 1.4 µm/y) larger IMT progression per 2.5 µg/m^3^ of PM~2.5~ and a 5.5 µm/y (95% CI 0.1--10.8 µm/y) larger progression for living within close proximity to a major roadway [@pmed.1001430-Kunzli2]. While we observed larger PM~2.5~ associations, the 1,483 adult participants of that collection of studies were slightly younger, more white and Hispanic, better educated, and with lower overall rates of progression than our cohort. In addition, that study used a different exposure prediction modeling approach and relied on far fewer air pollution monitors than were available to us, resulting in nearly 5 times less variable PM~2.5~ estimates for Los Angeles than in this investigation. Nevertheless, their PM~2.5~ association was well within our confidence intervals for MESA participants in Los Angeles (3.4 µm/y; 95% CI −0.002 to 6.8 µm/y per 2.5 µg/m^3^). Toxicological data also support our findings, with several studies documenting the growth of atherosclerotic lesions in the coronary arteries and aortas of rabbits and mice following controlled exposures to particulate matter. [@pmed.1001430-Suwa1]--[@pmed.1001430-Sun1],[@pmed.1001430-Sun2].

We also demonstrated positive cross-sectional associations between baseline IMT and long-term exposure but these were blunted and could not be distinguished from no association after control for metropolitan area. Associations similar to our between-city results have been previously reported for long-term exposure to PM~2.5~ among the older adults enrolled in the Los Angeles clinical trials [@pmed.1001430-Kunzli1], an earlier investigation of the MESA cohort at baseline [@pmed.1001430-Roux1], and a large population-based cohort of German older adults [@pmed.1001430-Bauer1]. In fact, our result of a 3--10 µm difference in IMT at baseline is very consistent with the range of 5 to 17 µm predicted by these other studies for the same unit change in PM~2.5~ and slightly higher than a recent investigation of young adults that reported a 2 µm larger IMT predicted per 2.5 µg/m^3^ [@pmed.1001430-Lenters1]. Associations between air pollution and other indicators of atherosclerosis extent have been somewhat suggestive but inconsistent [@pmed.1001430-Roux1],[@pmed.1001430-Hoffmann1]--[@pmed.1001430-Allen1]. Since our cross-sectional results were driven by differences in baseline IMT between the two areas with the highest (Los Angeles) and lowest (St Paul) concentrations of PM~2.5~, however, and were not robust to control for metropolitan area, there is the possibility of residual confounding by regional factors.

In contrast to our cross-sectional results for baseline IMT, associations with IMT progression were strongest after control for metropolitan area. The reasons for the opposite effect of site adjustment on associations with baseline IMT and IMT progression remain to be determined. Because cross-sectional associations with baseline IMT are based on between-person contrasts, these relations may be more affected by confounding by personal factors than those in our progression models, which leverage information from the same individual. Within-area associations for IMT progression showed little change with control for neighborhood socio-economic characteristics, personal education, and perceived noise and demonstrated positive associations across all six metropolitan areas in stratified analyses. Changes in concentrations over the follow-up period were also associated with IMT progression in models with and without control for metropolitan area. Thus, while some questions are raised as to the robustness of cross-sectional associations with baseline IMT, sensitivity analyses raise our confidence in the associations with IMT progression as potentially reflecting a causal association.

These data come from a well-defined prospective cohort study with an uncommonly rich set of air pollution measurements in participants\' communities and homes, including individual-level perceived noise exposures. The inclusion of noise data is a unique feature of this analysis as noise has generally not been accounted for in American epidemiological studies of air pollution to date. Although noise has been independently associated with cardiovascular disease and perceived noise was related to air pollution concentrations in MESA [@pmed.1001430-Allen2],[@pmed.1001430-Allen3], interestingly, we found no evidence of confounding of the relationship between air pollution and IMT progression by perceived noise in this analysis.

Despite the many strengths of this study, this work is not without its weaknesses. First, IMT likely does not capture all of the relevant pathophysiology related to air pollution exposures [@pmed.1001430-Liviakis1]. Second, our exposure assignment is currently limited to predictions of pollution from ambient origin after 1999 but restriction of the analysis to non-movers (≥10 y at baseline address) did not alter our findings. Third, we did not achieve complete follow-up of all participants and data. The probability of being lost to follow-up over these first three exams was unrelated to baseline IMT levels, however, and the likelihood of missing covariate or exposure data was also unrelated to baseline IMT or IMT progression. Missing covariate information was similarly unrelated to baseline exposure concentrations. This finding suggests that bias in our primary associations due to selection is unlikely although it is always a possibility in any longitudinal study. Furthermore, we are currently not accounting for changes in neighborhood characteristics that also may have occurred during the study period. Control for time-varying vascular risk factors in our extended adjustment model, which may capture some time-varying socio-economic trends, did not substantially alter our findings so we might hypothesize that this is not a major source of confounding. The lack of an association between reductions in air pollution and changes in healthy food stores is further supportive of this hypothesis. Nevertheless, future work through MESA will address this question more thoroughly as they explore the impacts of changing neighborhoods on health. Similarly, our exposure assessment does not currently account for the penetration of outdoor particles into indoor air but correlations of outdoor and indoor PM~2.5~ of outdoor origin have been shown to be high [@pmed.1001430-Sarnat1]. Future analyses of MESA Air will confirm the findings of this early dataset using IMT data collected during MESA clinical visits 4 and 5. These analyses will furthermore incorporate estimates of air pollution infiltration into participant homes and participant time-activity information, as well as investigate other correlated pollutants that may explain some of this PM~2.5~ association and explore relationships with clinical events.

Overall, these results for IMT in the first three exams of a large, multi-center, population-based cohort study support the hypothesis that PM~2.5~ may be associated with the progression of atherosclerosis, even at levels below existing regulatory standards. Such a pathway would lend further support to reported associations between air pollution and the incidence of clinical cardiovascular disease.
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